Leukemia Clinical Trials in Portland

Showing 841-860 of 921 trials

A Trial of Two Daclizumab Dosing Strategies vs. No Induction Treatment With Tacrolimus, Mycophenolate Mofetil , & Steroids for the Prevention of Acute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant Recipients

NCT00363116

The purpose of the study is to determine the safety and efficacy of two dosing regimens of daclizumab in simultaneous kidney/pancreas transplant recipients.

Acute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant Recipients

University of Cincinnati298 participantsStarted Apr 1999

Davis, California, United States • Los Angeles, California, United States • Washington D.C., District of Columbia, United States +21 more locations

COMPLETEDPhase 3< 1 mile

Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia

NCT00002812

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug and giving the drugs in different combinations may kill more cancer cells. PURPOSE: Randomized phase III trial to compare the effectiveness of standard combination chemotherapy treatment with more intensive combination chemotherapy in treating children with acute lymphocytic leukemia.

Leukemia

Children's Oncology Group2,078 participantsStarted Sep 1996

Long Beach, California, United States • Los Angeles, California, United States • Los Angeles, California, United States +32 more locations

A Trial of Two Daclizumab Dosing Strategies vs. No Induction Treatment With Tacrolimus, Mycophenolate Mofetil , & Steroids for the Prevention of Acute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant Recipients

Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia

Leukemia Trials in Other Cities

Study of Obatoclax in Previously Untreated Acute Myeloid Leukemia (AML)

Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia

Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia

Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults

Interleukin-2 in Treating Children Who Have Undergone Bone Marrow Transplantation for Acute Myeloid Leukemia

Safety of Adding IMO-2055 to Erlotinib + Bevacizumab in 2nd Line Treatment for Patients With NSCLC

Study of the Safety and Tolerability of PCI-32765 in Patients With Recurrent B Cell Lymphoma

Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLC

Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer

Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy

Study on OsseoSpeed™ Implants in Patients Missing 2-5 Teeth in the Posterior Lower Jaw, Restored With Permanent Teeth Attached 6-7 Weeks Later

Centralized Cord Blood Registry to Facilitate Unrelated Cord Blood Transplantation

The PediQUEST Study: Evaluation of Pediatric Quality of Life and Evaluation of Symptoms Technology

A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib Alone

A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy.

Cytarabine With or Without VNP40101M in Treating Patients With Relapsed Acute Myeloid Leukemia

Collaborative H1N1 Adjuvant Treatment Pilot Trial

Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the Pelvis

Other Conditions in Portland